Target intelligence / Profile preview

Prokaryotic large ribosomal subunit (50S) (50S subunit)

Target
50S subunit
Molecular classification
Ribosomal subunit, Ribonucleoprotein complex, Catalytic RNA (ribozyme), Other
01

Overview

The prokaryotic large ribosomal subunit (50S) is one of two major components of the bacterial ribosome, the site of protein synthesis in all bacteria. It is composed of 23S and 5S ribosomal RNA along with approximately 31–34 different proteins, forming a complex tertiary structure. The primary functions of the 50S subunit are catalyzing peptide bond formation (acting as a ribozyme at the peptidyl transferase center), providing a channel for the nascent polypeptide to exit, and binding various translation factors crucial for elongation, termination, and recycling. Many clinically important antibiotics selectively bind and inhibit the 50S subunit, making it a major validated antimicrobial target. Resistance can develop via target mutations, methylation of rRNA, or alteration in ribosomal proteins. The structural and functional integrity of the 50S subunit is essential for cell viability, and its exclusive features versus the eukaryotic 60S homolog permit therapeutic selectivity for bacterial infections[1][2][3][4][5][7].

Other names
50S ribosomal subunitBacterial large ribosomal subunitRibosome 50S subunitLarge subunit of prokaryotic ribosome
02

Mechanism of action

Inhibition of peptide bond formation at the peptidyl transferase center; Blockage of polypeptide exit tunnel; Prevention of ribosomal translocation; Disruption of ribosomal assembly

03

Biological functions

Protein synthesis (translation)Peptide bond formationPolypeptide exit channelBinding site for translation factors
04

Disease associations

InfectionAntibiotic resistance
05

Safety considerations

Selectivity versus human ribosome (cytotoxicity potential)Development of antibiotic resistance (target mutations/methylation)Drug-drug interactions (especially for broad-spectrum inhibitors)
06

Interacting drugs

Macrolides (e.g., erythromycin, azithromycin)

5 more in the full profile.

07

Biomarkers

Mutations in 23S rRNA (e.g., A2058G) for macrolide resistanceMethylation status of 23S rRNA (e.g., Erm methyltransferase activity)Ribosomal protein composition (relevant in diagnostic resistance panels)

Beyond the preview

Go deeper on Prokaryotic large ribosomal subunit (50S) (50S subunit).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prokaryotic large ribosomal subunit (50S) (50S subunit).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call